Table 2.
Characteristics of serotype-specific neutralizing antibody response by PRNT50 of the dengue patients stratified by dengue severity
| Characteristics | Severe denguea
n = 40 |
Dengue n = 20 |
|---|---|---|
| Antibody response | ||
| Monotypic, (%) | 6(15.0) | 3(15.0) |
| DENV-1 | 2 | 1 |
| DENV-2 | - | 2 |
| DENV-3 | - | - |
| DENV-4 | 4 | - |
| Multitypic dual, (%) | 11(27.5) | 4(20.0) |
| DENV-1/DENV-2 | 4 | - |
| DENV-1/DENV-3 | - | 1 |
| DENV-1/DENV-4 | 1 | - |
| DENV-2/DENV-4 | 1 | 3 |
| DENV-3/DENV-4 | 5 | - |
| Multitypic three or more, (%) | 23(57.5) | 13(65.0) |
| DENV-1/DENV-2/DENV-3 | 3 | 3 |
| DENV-1/DENV-2/DENV-4 | 4 | 1 |
| DENV-1/DENV-3/DENV-4 | 5 | - |
| DENV-2/DENV-3/DENV-4 | 2 | 2 |
| DENV-1/DENV-2/DENV-3/DENV-4 | 9 | 7 |